AGP Executive Report
Last update: 6 hours agoFDA Approvals: Moderna’s mRNA flu vaccine mFlusiva is cleared for adults 50+ as the first new seasonal flu option built on an mRNA platform, with phase 3 data supporting prevention of flu A and B. Cancer Care Breakthrough: Replimune’s oncolytic virus therapy Tudriqev (with Opdivo) wins FDA accelerated approval for advanced melanoma after a tough review history and reliance on an ongoing Phase 3 trial. Digital Health & Monitoring: iRhythm signs to acquire VitalConnect, expanding wearable and ambulatory cardiac monitoring with added continuous multi-vitals capabilities. Hospital Operations: A push for RFID tracking aims to cut medication waste and inventory gaps that leave billions in unused drugs expiring while patients wait. Workforce & Advocacy: Maine nurses celebrate the release of detained colleague Debora Kapisha from ICE and renew calls for hospital action. Nursing & Mental Health: Nursing Times Awards 2025 highlight mental health nursing leaders and finalists, including forensic pathways for autistic people and adults with learning disabilities. Global Health Access: Bangladesh launches “Health Express” to bring ultrasound training and equipment to underserved districts. Clinical Safety in Real Time: CCTV from a Japan quake shows staff clinging to a shaking operating table while treating a patient.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
